Stockreport

J&J Wants A Piece Of Gilead's HIV Market [Seeking Alpha]

Johnson & Johnson  (JNJ) 
Last johnson & johnson earnings: 4/14 06:31 am Check Earnings Report
US:NYSE Investor Relations: jnj.com
PDF Summary Johnson & Johnson announced that it had obtained FDA approval for its HIV drug Symtuza (darunavir). Approval for the treatment of patients with [Read more]